In our study, we proposed that the interaction between CD155 and SRC resulted in augmented SRC activation by disrupting the intramolecular interaction that held SRC in a close molecular structure, representing a new mechanism for the abnormal activation of SRC in HCC. Here, PVR is linked to hepatocellular carcinoma.